MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

AKT-IN-6

CAS No. : 1430056-54-4

MCE 站：AKT-IN-6

产品活性：AKT-IN-6 (Example 13) 是一种有效的 AKT 抑制剂。AKT-IN-6抑制 Akt1、Akt2 和 Akt3， IC₅₀s 分别 < 500nM，来自WO201305615A1。

研究领域：PI3K/Akt/mTOR

作用靶点：Akt

In Vitro: Akt is a central node in cell signaling downstream of growth factors, cytokines, ａnd other cellular stimuli. Aberrant loss or gain of Akt activation underlies the pathophysiological properties of a variety of complex diseases, including type-2 diabetes ａnd cancer.

相关产品：Bioactive Compound Library Plus  |  Kinase Inhibitor Library  |  PI3K/Akt/mTOR Compound Library  |  Stem Cell Signaling Compound Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Differentiation Inducing Compound Library  |  Diabetes Related Compound Library  |  Oxygen Sensing Compound Library  |  Glycolysis Compound Library  |  Cytoskeleton Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Breast Cancer Compound Library  |  Anti-Lung Cancer Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  Anti-Cancer Metabolism Compound Library  |  Angiogenesis Related Compound Library  |  Glucose Metabolism Compound Library  |  MK-2206 dihydrochloride  |  SC79  |  Capivasertib  |  Ipatasertib  |  Honokiol  |  GSK-690693  |  AKT inhibitor VIII  |  Artemisinin  |  Guggulsterone  |  Oridonin  |  Miransertib  |  Recilisib  |  Perifosine  |  Afuresertib  |  Triciribine  |  SU6656  |  A-443654  |  Scutellarin  |  α-Linolenic acid  |  Uprosertib  |  Isobavachalcone  |  Miltefosine  |  A-674563 hydrochloride  |  Deguelin  |  YS-49  |  CCT128930  |  Urolithin B  |  AT13148  |  LM22B-10

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。